Seizert Capital Partners’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-152,428
| Closed | -$5.11M | – | 222 |
|
|
2016
Q4 | $5.11M | Buy |
152,428
+238
| +0.2% | +$7.97K | 0.18% | 76 |
|
|
2016
Q3 | $4.05M | Sell |
152,190
-12,661
| -8% | -$337K | 0.15% | 77 |
|
|
2016
Q2 | $3.64M | Buy |
164,851
+47,060
| +40% | +$1.04M | 0.14% | 83 |
|
|
2016
Q1 | $3.46M | Buy |
117,791
+17,640
| +18% | +$518K | 0.12% | 101 |
|
|
2015
Q4 | $3.31M | Buy |
100,151
+5,693
| +6% | +$188K | 0.1% | 118 |
|
|
2015
Q3 | $3.41M | Buy |
94,458
+10,853
| +13% | +$392K | 0.1% | 114 |
|
|
2015
Q2 | $3.76M | Buy |
+83,605
| New | +$3.76M | 0.1% | 114 |
|